LEMAITRE VASCULAR INC·4

Jun 5, 5:37 PM ET

O'Connor John James 4

4 · LEMAITRE VASCULAR INC · Filed Jun 5, 2026

Research Summary

AI-generated summary of this filing

Updated

LEMAITRE VASCULAR (LMAT) Director John O'Connor Receives Award

What Happened

  • Director John O'Connor was credited with five dividend-equivalent awards on 2026-06-04, totaling 4.071 dividend-equivalent rights (0.466 + 0.558 + 0.76 + 0.86 + 1.427). Each was reported as an acquisition (code A) at $0.00 — these are derivative, non-cash accruals tied to existing restricted stock unit (RSU) and performance share unit (PSU) awards. The filing reports $0 cash value for these entries because they are dividend equivalents that vest proportionately with the underlying awards.

Key Details

  • Transaction date: 2026-06-04; Form 4 filed: 2026-06-05 (timely).
  • Reported entries: 0.466, 0.558, 0.76, 0.86, and 1.427 dividend-equivalent rights; price per unit reported $0.00.
  • Shares owned after transaction: not specified in the provided filing excerpt.
  • Footnotes: each amount represents dividend-equivalent rights that accrued on prior awards and vest proportionately:
    • F1: accrued on RSU grant dated 12/8/2023
    • F2: accrued on PSU grant dated 12/8/2023
    • F3: accrued on RSU grant dated 12/6/2024
    • F4: accrued on PSU grant dated 12/6/2024
    • F5: accrued on RSU grant dated 12/10/2025
  • Transaction code: A = Award/Grant (derivative accruals), not a cash purchase or sale.

Context

  • Dividend-equivalent rights are bookkeeping credits that mirror dividends on underlying RSUs/PSUs and generally vest according to the schedule of the original awards; they are not immediate open-market purchases or sales. Such accruals are routine compensation mechanics and do not necessarily indicate a personal buy/sell decision by the insider.

Insider Transaction Report

Form 4
Period: 2026-06-04
Transactions
  • Award

    Dividend Equivalent Rights

    [F1]
    2026-06-04+0.4665.067 total
    Common Stock (0.466 underlying)
  • Award

    Dividend Equivalent Rights

    [F2]
    2026-06-04+0.5584.869 total
    Common Stock (0.558 underlying)
  • Award

    Dividend Equivalent Rights

    [F3]
    2026-06-04+0.764.298 total
    Common Stock (0.76 underlying)
  • Award

    Dividend Equivalent Rights

    [F4]
    2026-06-04+0.864.484 total
    Common Stock (0.86 underlying)
  • Award

    Dividend Equivalent Rights

    [F5]
    2026-06-04+1.4272.635 total
    Common Stock (1.427 underlying)
Footnotes (5)
  • [F1]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F2]These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F3]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F4]These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
  • [F5]These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Signature
/s/ Laurie A. Churchill, Attorney-in-fact|2026-06-05

Documents

1 file
  • 4
    ownership.xmlPrimary

    4